Research Article
A Novel Four-Gene Prognostic Signature as a Risk Biomarker in Cervical Cancer
Table 1
Clinical features of CC patients in the training and verification groups.
| Feature | Training group () | Verification group () | value |
| Age | | | | ≤64 | 129 | 136 | 0.304 | >64 | 23 | 16 | | Grade | | | | G1-G2 | 79 | 74 | 0.834 | G3 | 58 | 61 | | Unknown | 15 | 17 | | FIGO stage | | | | I-II | 112 | 119 | 0.607 | III-IV | 36 | 29 | | Unknown | 4 | 4 | | LNM status | | | | Positive | 60 | 73 | 0.278 | Negative | 34 | 26 | | Unknown | 58 | 53 | | Race | | | | White | 118 | 121 | 0.700 | Asian | 9 | 11 | | Other | 4 | 5 | | Not reported | 21 | 15 | |
|
|
CC: cervical cancer; FIGO: Fédération Internationale de Gynécologie et d’Obstétrique; LNM: lymph node metastasis.
|